Breaking News Instant updates and real-time market news.

VIVE

Viveve

$2.34

-0.24 (-9.30%)

08:29
08/07/18
08/07
08:29
08/07/18
08:29

Viveve announces FDA approval to continue VIVEVE II clinical study

Viveve Medical announced that it has received clearance from the U.S. Food and Drug Administration to continue enrollment in the company's multicenter randomized Viveve Treatment of the Vaginal Introitus to EValuate Safety and Efficacy clinical trial to assess the safety and effectiveness of the Viveve System for the improvement of sexual function in women following vaginal childbirth. The Agency's approval was based on a determination that the company provided sufficient data to support continued subject enrollment in the trial and that there are no subject protection concerns that preclude continuation of the study. "This clearance to continue enrollment represents a major step forward in the progression of the VIVEVE II trial and for women seeking an improvement in sexual function following child birth. Following FDA review of the second stage of safety data, and approval of an IDE supplement to expand the study, Viveve plans to continue enrollment up to 250 patients," stated CEO Scott Durbin.

  • 09

    Aug

VIVE Viveve
$2.34

-0.24 (-9.30%)

06/19/18
MAXM
06/19/18
NO CHANGE
Target $9
MAXM
Buy
Maxim remains a buyer of Viveve shares after data report
Maxim analyst Anthony Vendetti would continue to be a buyer of Viveve shares after the company's report of positive interim 6-month data from its ongoing 12-month SUI feasibility study. He views SUI as another large market for the company and believes the company's multi-pronged approach of pursuing SUI and female sexual function indications can provide a significant competitive edge for the Viveve System. He maintains a Buy rating and $9 price target on Viveve shares.
07/11/18
MZHO
07/11/18
NO CHANGE
Target $4
MZHO
Buy
Viveve Q2 results 'step in the right direction,' says Mizuho
Mizuho analyst Difei Yang views Viveve Medical's preliminary Q2 results as a "step in the right direction" as revenue topped expectations and 2018 guidance was reaffirmed. However, it is "premature to declare victory," as the growth trend of treatment tips needs to be further understood, Yang tells investors in a research note. She keeps a Buy rating on Viveve with a $4 price target.
07/30/18
CHLM
07/30/18
NO CHANGE
CHLM
Hold
FDA warning to off-label competitors positive for Viveve, says Craig-Hallum
Craig-Hallum analyst Matt Hewitt noted that the FDA published seven "Letters to Industry" that were sent to companies that may be violating the law for inappropriately marketing their energy-based devices for vaginal "rejuvenation," but noted that Viveve (VIVE) was not amongst them. He views this as a positive for Viveve, as it signals that the FDA is cracking down on the off-label promotion that he thinks has been a key commercial challenge for the company. Viveve is the only one in the space currently performing a trial for sexual function, placing it "miles ahead of the competition" in terms of obtaining an actual label, added Hewitt, who keeps a Hold rating on the stock due to concerns over the company's operating cash flow burn and uncertainty about financials. The Fly notes that Cynosure, a unit of Hologic (HOLX), was among the companies to receive an FDA warning.
07/31/18
MZHO
07/31/18
NO CHANGE
Target $4
MZHO
Buy
Seven Viveve competitors get FDA warning letters, says Mizuho
The FDA issued a warning letter to seven competitors of Viveve Medical related to the inappropriate marketing of energy-based devices for the treatment of vaginal rejuvenation, Mizuho analyst Difei Yang tells investors in a research note. The analyst anticipates the competitors will likely stop marketing their devices "off label" in the near term. Since Viveve has not received a letter, Yang sees the development as a positive for the company. The letters to competitors will likely provide an opportunity to compete on equal footing with more established players, especially considering Viveve has received two investigational device exemptions from the FDA to conduct clinical trials in both sexual function and stress urinary incontinence, Yang tells investors in a research note. She reiterates a Buy rating on Viveve shares with a $4 price target.

TODAY'S FREE FLY STORIES

VNOM

Viper Energy

$38.34

0.91 (2.43%)

21:49
08/16/18
08/16
21:49
08/16/18
21:49
Upgrade
Viper Energy rating change  »

Viper Energy upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LIFE

aTyr Pharma

$0.63

(0.00%)

21:45
08/16/18
08/16
21:45
08/16/18
21:45
Upgrade
aTyr Pharma rating change  »

aTyr Pharma upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HLT

Hilton

$77.25

1.04 (1.36%)

21:44
08/16/18
08/16
21:44
08/16/18
21:44
Downgrade
Hilton rating change  »

Hilton downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$335.46

-3.2 (-0.94%)

20:50
08/16/18
08/16
20:50
08/16/18
20:50
Periodicals
Tesla Fremont facility workers left 3.5 hours early on Wednesday, BI reports »

Workers at Tesla's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

SPX

S&P 500

$0.00

(0.00%)

, FXI

iShares China Large-Cap ETF

$41.00

0.41 (1.01%)

20:43
08/16/18
08/16
20:43
08/16/18
20:43
Periodicals
Pentagon: China expanded bomber training to overwater areas, Reuters says »

In its annual report, the…

SPX

S&P 500

$0.00

(0.00%)

FXI

iShares China Large-Cap ETF

$41.00

0.41 (1.01%)

BA

Boeing

$345.89

14.16 (4.27%)

HII

Huntington Ingalls

$244.50

3.68 (1.53%)

LMT

Lockheed Martin

$325.86

8.31 (2.62%)

NOC

Northrop Grumman

$291.97

0.45 (0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DE

Deere

$137.38

1.68 (1.24%)

20:25
08/16/18
08/16
20:25
08/16/18
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Aug

MCD

McDonald's

$161.71

1.82 (1.14%)

19:48
08/16/18
08/16
19:48
08/16/18
19:48
Hot Stocks
FDA updates on investigation of McDonald's salad-related Cyclospora illnesses »

As of August 16, 2018, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

TRP

TransCanada

$43.82

0.05 (0.11%)

19:40
08/16/18
08/16
19:40
08/16/18
19:40
Hot Stocks
TransCanada does not endorse mini-tender by TRC Capital »

TransCanada has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SGMS

Scientific Games

$30.70

1.4 (4.78%)

, INSE

Inspired Entertainment

$7.15

(0.00%)

19:21
08/16/18
08/16
19:21
08/16/18
19:21
Hot Stocks
Scientific Games and Pennsylvania Lottery launch virtual sports »

Scientific Games (SGMS)…

SGMS

Scientific Games

$30.70

1.4 (4.78%)

INSE

Inspired Entertainment

$7.15

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KRYS

Krystal Biotech

$15.63

0.23 (1.49%)

19:19
08/16/18
08/16
19:19
08/16/18
19:19
Syndicate
Krystal Biotech announces $10M private placement with Frazier Healthcare »

Krystal Biotech announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

LBC

Luther Burbank

$10.90

-0.09 (-0.82%)

19:08
08/16/18
08/16
19:08
08/16/18
19:08
Hot Stocks
Luther Burbank authorizes stock buyback of up to $15M »

Luther Burbank…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

ARAY

Accuray

$3.50

0.05 (1.45%)

, JWN

Nordstrom

$52.30

0.44 (0.85%)

19:00
08/16/18
08/16
19:00
08/16/18
19:00
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS:…

ARAY

Accuray

$3.50

0.05 (1.45%)

JWN

Nordstrom

$52.30

0.44 (0.85%)

CRMT

America's Car-Mart

$66.95

1.85 (2.84%)

ATAI

ATA Inc.

$6.87

0.13 (1.93%)

CORT

Corcept Therapeutics

$12.51

0.01 (0.08%)

VJET

voxeljet

$3.51

0.11 (3.24%)

VNET

21Vianet

$9.45

0.44 (4.88%)

ATGE

Adtalem Global Education

$55.70

-0.3 (-0.54%)

NVDA

Nvidia

$257.57

-1.41 (-0.54%)

AMAT

Applied Materials

$47.42

-0.07 (-0.15%)

MU

Micron

$47.10

-0.38 (-0.80%)

LRCX

Lam Research

$174.22

1.42 (0.82%)

ZOES

Zoe's Kitchen

$9.52

0.04 (0.42%)

VCEL

Vericel

$11.50

-0.075 (-0.65%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

  • 16

    Aug

  • 16

    Aug

  • 16

    Aug

  • 16

    Aug

  • 16

    Aug

  • 17

    Aug

  • 17

    Aug

  • 22

    Aug

  • 04

    Sep

  • 05

    Sep

  • 12

    Sep

  • 27

    Sep

  • 06

    Nov

NVEE

NV5 Global

$84.05

1.55 (1.88%)

18:55
08/16/18
08/16
18:55
08/16/18
18:55
Hot Stocks
NV5 Global CEO sells 190,500 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Sep

  • 20

    Sep

  • 21

    Sep

GOOG

Alphabet

$1,206.00

-7.65 (-0.63%)

, GOOGL

Alphabet Class A

$1,223.55

-8.75 (-0.71%)

18:54
08/16/18
08/16
18:54
08/16/18
18:54
Periodicals
Google submits plans for Moffett Park development, SVBJ reports »

Alphabet's Google…

GOOG

Alphabet

$1,206.00

-7.65 (-0.63%)

GOOGL

Alphabet Class A

$1,223.55

-8.75 (-0.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 18

    Sep

  • 20

    Sep

  • 28

    Oct

WMT

Walmart

$98.63

8.39 (9.30%)

18:38
08/16/18
08/16
18:38
08/16/18
18:38
Recommendations
Walmart analyst commentary at Baird »

Walmart price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

AVEO

Aveo Pharmaceuticals

$2.26

0.085 (3.91%)

18:35
08/16/18
08/16
18:35
08/16/18
18:35
Syndicate
Aveo Pharmaceuticals files to sell common stock, no amount given »

Piper Jaffray & Co.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

ZN

Zion Oil & Gas

$2.53

0.16 (6.75%)

18:15
08/16/18
08/16
18:15
08/16/18
18:15
Hot Stocks
Zion Oil & Gas confirms active petroleum system in Megiddo-Jezreel #1 well »

Zion Oil & Gas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRS

Amyris

$7.49

0.07 (0.94%)

18:14
08/16/18
08/16
18:14
08/16/18
18:14
Syndicate
Amyris files to sell 7.4M shares of common stock for holders »

In connection with the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CORT

Corcept Therapeutics

$12.51

0.01 (0.08%)

18:07
08/16/18
08/16
18:07
08/16/18
18:07
Hot Stocks
Corcept Therapeutics board member Leonard Baker buys $2.2M in common stock »

Corcept Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 12

    Sep

ETSY

Etsy

$45.68

0.83 (1.85%)

17:44
08/16/18
08/16
17:44
08/16/18
17:44
Hot Stocks
Etsy chairman Frederick Wilson sells $1M in common stock »

Etsy chairman Frederick…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

NVDA

Nvidia

$257.57

-1.41 (-0.54%)

, TCEHY

Tencent

$0.00

(0.00%)

17:37
08/16/18
08/16
17:37
08/16/18
17:37
Hot Stocks
Nvidia says 'Fortnite,' 'PUBG' have strengthened video game market »

Nvidia (NVDA) says gaming…

NVDA

Nvidia

$257.57

-1.41 (-0.54%)

TCEHY

Tencent

$0.00

(0.00%)

DIS

Disney

$112.49

-0.42 (-0.37%)

MSFT

Microsoft

$107.65

-0.02 (-0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

  • 04

    Sep

  • 12

    Sep

RCUS

Arcus Biosciences

$12.89

-0.05 (-0.39%)

17:37
08/16/18
08/16
17:37
08/16/18
17:37
Hot Stocks
Arcus Biosciences CEO Terry Rosen buys over 28K shares of company stock »

Arcus Biosciences CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

GLD

SPDR Gold Trust

$111.11

-0.1 (-0.09%)

17:30
08/16/18
08/16
17:30
08/16/18
17:30
Hot Stocks
SPDR Gold Trust holdings fall to 773.41MT from 774.59MT »

This is the 4th…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FSTR

L.B. Foster

$23.05

-0.1 (-0.43%)

17:28
08/16/18
08/16
17:28
08/16/18
17:28
Hot Stocks
Breaking Hot Stocks news story on L.B. Foster »

Legion Partners lowers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HALO

Halozyme

$17.10

-0.1 (-0.58%)

17:25
08/16/18
08/16
17:25
08/16/18
17:25
Hot Stocks
Halozyme director and beneficial owner Randal Kirk sells over 490K shares »

Halozyme director and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.